Jacobs Levy Equity Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.99M | Sell |
|
|||||
|
2025
Q2 | $6.79M | Sell |
|
|||||
|
2025
Q1 | $9.83M | Buy |
|
|||||
|
2024
Q4 | $9.17M | Sell |
|
|||||
|
2024
Q3 | $60.4M | Sell |
|
|||||
|
2024
Q2 | $99.3M | Buy |
|
|||||
|
2024
Q1 | $98.3M | Sell |
|
|||||
|
2023
Q4 | $99.2M | Buy |
|
|||||
|
2023
Q3 | $77.9M | Buy |
|
|||||
|
2023
Q2 | $41.1M | Buy |
|
|||||
|
2023
Q1 | $43.7M | Buy |
|
|||||
|
2022
Q4 | $7.66M | Buy |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $605K | Sell |
|
|||||
|
2020
Q3 | $3.03M | Buy |
|
|||||
|
2020
Q2 | $3.36M | Sell |
|
|||||
|
2020
Q1 | $13M | Sell |
|
|||||
|
2019
Q4 | $17.4M | Buy |
|
|||||
|
2019
Q3 | $10.3M | Sell |
|
|||||
|
2019
Q2 | $11.3M | Buy |
|
|||||
|
2019
Q1 | $7.42M | Buy |
|